Table 4.
Drugs withdrawn due to QT-prolongation.
| Drug | Date withdrawn | Reference |
|---|---|---|
| Terodiline | 1991 | Shah (2006) |
| Terfenadine (seldane) | 1998 | Shah (2006) |
| Mibefradil (posicor) | 1998 | Shah (2006) |
| Sertindole | 1998 | Shah (2006) |
| Astemizole (hismanal) | 1999 | Shah (2006) |
| Grepafloxacin (raxar) | 1999 | Shah (2006) |
| Cisapride (propulsid) | 2000 | http://www.medscape.com/viewarticle/446682 |
| Droperidol | 2001 | Shah (2006) |
| Sparfloxacin (zagam) | 2001 | Fluoroquinolones and QT-prolongation research continues http://www.infectiousdiseasenews.com/article/33493.aspx |
| Levacetylmethadol | 2001 | Shah (2006) |
| Dofetilide | 2004 | Shah (2006) |
| Thioridazine | 2005 | Shah (2006) |
| Quinidine | 2006 | Olsson (2010) |
| Halofantrine | ? | Lin et al. (2011) |
| Anzemet (injection form) | 2011 | Sanofi Aventis (2011) |
| Pimozide (orap) | ? | Lin et al. (2011) |
| Haloperidol (haldol) | ? | Lin et al. (2011) |
| Erythromycin | ? | Lin et al. (2011) |
| Lidoflazine | ? | Oshiro et al. (2010) |